Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intra-abdominal Hypertension in Critically Ill Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02514135
Recruitment Status : Completed
First Posted : August 3, 2015
Last Update Posted : August 27, 2018
Sponsor:
Information provided by (Responsible Party):
Patrick Murphy, Western University, Canada

Brief Summary:
The aim of the proposed study is to determine the incidence and prevalence of intra-abdominal hypertension and abdominal compartment syndrome in consecutive intensive care admissions using broad inclusion criteria.

Condition or disease Intervention/treatment
Intra-Abdominal Hypertension Abdominal Compartment Syndrome Other: No intervention

Detailed Description:
Increased pressure within the abdominal cavity is particularly common in intensive care patients and has been shown to be an independent risk-factor for mortality in this patient population. The quoted rates of intra-abdominal hypertension of range anywhere from 20-60% are dependent on the population of patient studied. The prospective observational studies performed to date have been underpowered, used strict inclusion/exclusion criteria or were performed prior to consensus guidelines on the definition and measurement of intra-abdominal pressure and hypertension.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 286 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Intra-abdominal Hypertension in Critically Ill Patients
Actual Study Start Date : September 1, 2015
Actual Primary Completion Date : January 30, 2016
Actual Study Completion Date : May 30, 2016

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Elevated Intra-abdominal Pressure
Patients with intra-abdominal pressure > 12 mmHg at any time throughout admission
Other: No intervention
Normal Intra-abdominal Pressure
Patients with intra-abdominal pressure < 12 mmHg throughout admission
Other: No intervention



Primary Outcome Measures :
  1. Mortality [ Time Frame: While patient in-hospital, expected stay one week on average ]
    As measured prospectively by patient death in the ICU


Secondary Outcome Measures :
  1. Length of stay [ Time Frame: While patient in-hospital, expected stay one week on average ]
    Measured prospectively from date of admission to ICU to death, or discharge from ICU

  2. Abdominal decompression [ Time Frame: While patient in-hospital, expected stay one week on average ]
    Midline laparotomy for abdominal compartment syndrome



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All adults (>18 years of age) admitted to the intensive care unit at Victoria Hospital, London, Ontario who have a Foley catheter in-situ
Criteria

Inclusion Criteria:

  • Foley catheter in-situ on admission

Exclusion Criteria:

  • Contra-indication to bladder pressure measurement
  • Home service asked that patient is not included
  • Death within 24 priors of admission before bladder pressure measured
  • No bladder pressure performed within 24 hours of admission
  • Consent refused or unable to be obtained (lack of SDM, patient unable to provide)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02514135


Locations
Layout table for location information
Canada, Ontario
Victoria Hospital
London, Ontario, Canada, N6K 1C2
Sponsors and Collaborators
Western University, Canada
Investigators
Layout table for investigator information
Principal Investigator: Kelly N Vogt, MD Western University
Publications:
Layout table for additonal information
Responsible Party: Patrick Murphy, Resident, Western University, Canada
ClinicalTrials.gov Identifier: NCT02514135    
Other Study ID Numbers: WesternUCanada
First Posted: August 3, 2015    Key Record Dates
Last Update Posted: August 27, 2018
Last Verified: August 2018
Additional relevant MeSH terms:
Layout table for MeSH terms
Compartment Syndromes
Intra-Abdominal Hypertension
Hypertension
Vascular Diseases
Cardiovascular Diseases
Muscular Diseases
Musculoskeletal Diseases